Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Carcinoma, Renal Cell 145 Kidney Neoplasms 42 Neoplasms 39 Neoplasm Metastasis 35 Breast Neoplasms 33 Gastrointestinal Stromal Tumors 31 Carcinoma, Non-Small-Cell Lung 22 Prostatic Neoplasms 16 Urinary Bladder Neoplasms 13 Colorectal Neoplasms 12 Brain Neoplasms 12 Pancreatic Neoplasms 11 Glioblastoma 11 Carcinoma, Hepatocellular 11 Melanoma 10 Lung Neoplasms 10 Carcinoma 10 Stomach Neoplasms 8 Neuroendocrine Tumors 8 Thyroid Neoplasms 7 Sarcoma 7 Ovarian Neoplasms 7 Multiple Myeloma 7 Liver Neoplasms 7 Adenoma, Islet Cell 7 Small Cell Lung Carcinoma 6 Leukemia, Myeloid, Acute 6 Glioma 6 Esophageal Neoplasms 6 Clear-cell metastatic renal cell carcinoma 6

Interventions

relacorilant 5 Nutrition Assessment 4 Hydrochlorothiazide 4 Bevacizumab 3 Amlodipine 3 aliskiren 2 Osilodrostat 2 Lisinopril 2 Labetalol 2 Angiotensin-Converting Enzyme Inhibitors 2 Adrenalectomy 2 ziprasidone 1 sacubitril and valsartan sodium hydrate drug combination 1 pembrolizumab 1 pazopanib 1 lutetium Lu 177 dotatate 1 ganirelix 1 gallium Ga 68 dotatate 1 fimasartan 1 enzalutamide 1 clevidipine 1 cediranib 1 bicalutamide 1 benazepril 1 Zolpidem 1 Warfarin 1 Vitamin D 1 Vecuronium Bromide 1 Vancomycin 1 Urine Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Hypertension × Sunitinib × Clear all

NCT04368546 2021-01-27

Sunitinib Treatment on Tissue Sodium Accumulation (TSS2)

Charite University, Berlin, Germany

Hypertension

Data powered by HemOnc (CC BY 4.0) Colophon ⚡